Skip to main content
Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.47
-0.14 (-1.46%)
At close: Nov 22, 2024, 4:00 PM
9.50
+0.03 (0.32%)
After-hours: Nov 22, 2024, 5:41 PM EST

Theravance Biopharma Revenue

Theravance Biopharma had revenue of $16.87M in the quarter ending September 30, 2024, with 7.49% growth. This brings the company's revenue in the last twelve months to $63.19M, up 15.93% year-over-year. In the year 2023, Theravance Biopharma had annual revenue of $57.42M with 11.84% growth.

Revenue (ttm)
$63.19M
Revenue Growth
+15.93%
P/S Ratio
7.32
Revenue / Employee
$638,303
Employees
99
Market Cap
465.68M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202357.42M6.08M11.84%
Dec 31, 202251.35M-3.97M-7.17%
Dec 31, 202155.31M-16.55M-23.03%
Dec 31, 202071.86M-1.56M-2.12%
Dec 31, 201973.41M13.04M21.61%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xeris Biopharma Holdings 187.36M
SIGA Technologies 173.73M
Y-mAbs Therapeutics 84.55M
REGENXBIO 84.33M
Semler Scientific 58.94M
Cartesian Therapeutics 47.94M
OmniAb 20.41M
MeiraGTx Holdings 13.93M
Revenue Rankings

TBPH News

More News